logo

For the Inventor, By the Inventor

Jena, Germany

Birgitt Schneider

This inventor holds 17 USPTO granted patents and 2 EPO patents. Top assignees: Jenapharm Gmbh & Co. Kg, Schering Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 1997-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Birgitt Schneider. Retrieved from https://idiyas.com/inventor/birgitt-schneider

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 64.7


Average Co-Inventor Count = 6.5

ph-index = 7

Forward Citations = 174(Granted Patents)


Company Filing History:

goldMedal6 out of 26 
 
Jenapharm Gmbh & Co. Kg
 patents
silverMedal6 out of 1,409 
 
Schering Aktiengesellschaft
 patents
bronzeMedal4 out of 192 
 
Bayer Schering Pharma Ag
 patents
4. 1 out of 1 
 
Entec Gesellschaft Fuer Endokrinologische Technologie M.b.h.
 patent

Years Active: 1997-2010

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 7732493 - 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 (2010-06-08),
2. 7550451 - Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy (2009-06-23),
3. 7534780 - Estradiol prodrugs (2009-05-19),
4. 7435757 - 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 (2008-10-14),
5. 7419972 - 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 (2008-09-02),
6. 7388003 - [object Object] (2008-06-17),
7. 7199115 - 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them (2007-04-03),
8. 6841548 - Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives (2005-01-11),
9. 6825182 - 17&agr;-fluoroalkyl-11&bgr;-benzaldoxime steroids, process for their production, pharmaceutical preparations that contain these steroids as well as their use for the production of pharmaceutical agents (2004-11-30),
10. 6583130 - C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds (2003-06-24),
11. 6569844 - Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives (2003-05-27),
12. 6534490 - Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds (2003-03-18),
13. 6436917 - Non-estrogenic estradiol derivative compounds with anti-oxidative activity (2002-08-20),
14. 6388109 - 14,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds (2002-05-14),
15. 6080735 - Estra-1,3,5(10)-trien derivatives, processes for their preparation and (2000-06-27),

Title: The Innovative Contributions of Birgitt Schneider

Introduction

Birgitt Schneider is a prominent inventor based in Jena, Germany. With an impressive portfolio of 17 patents, Schneider has greatly contributed to the advancement of pharmaceutical innovations, particularly in the fields of birth control and hormone replacement therapy. Her groundbreaking work continues to influence the medical community, providing novel solutions for women's health issues.

Latest Patents

Among her latest patents, Schneider has developed "2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1." This invention focuses on new 2-substituted D-homo-estra-1,3,5(10)-trienes, addressing important therapeutic targets in hormonal regulation. Additionally, she holds a patent for "Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy," which involves novel compounds designed for female contraceptive solutions and hormone therapy applications.

Career Highlights

Birgitt Schneider's career includes significant contributions while working for reputable companies such as Jenapharm GmbH & Co. KG and Schering Aktiengesellschaft. Her experience in these organizations has allowed her to push the boundaries of innovation in pharmaceuticals, particularly focusing on women's health alternatives.

Collaborations

Throughout her career, Schneider has collaborated with esteemed colleagues, including Walter Elger and Gudrun Reddersen. These collaborations have helped foster an environment of creativity and innovation, leading to many of her patent achievements that have made a positive impact on healthcare.

Conclusion

Birgitt Schneider is a distinguished inventor whose work continues to shape the future of women's health solutions. Her inventive spirit and dedication to medical advancements are evident through her multiple patents and collaborative efforts, making her a key figure in her field. The contributions of Schneider are not only significant for her immediate community but also resonate globally, paving the way for new horizons in pharmaceutical research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…